Analysis of survival data with missing measurements of a time-dependent binary covariate

Journal of Biopharmaceutical Statistics

Volumn 13, Issue 2, 2003, Pages 253-270

  Halabi, Susan ^a   Wun, Chuan Chuan ^b   Davis, Barry R ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Imputation; Last observation carried forward; Negative lag 1 correlation; Proportional hazards model; Survival analysis; Time dependent covariate

Indexed keywords

ATENOLOL; CHLORTALIDONE; PLACEBO; RESERPINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DATA ANALYSIS; ELDERLY CARE; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; NONBIOLOGICAL MODEL; OBSERVATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLING; SURVIVAL; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TIME DEPENDENT BINARY COVARIATE;

HUMANS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0037279011     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-120019270     Document Type: Article

References (19)

1. Albridge, K. M., Standish, J., Fries, J. F. (1988). Hierarchical time-oriented approaches to missing data inference. Comput. Biomed. Res. 21:349-366.
2. Altman, D. G., De Stavola, B. I. (1994). Practical problems in fitting a proportional hazards model to data with updated measurements of the covariates. Stat. Med. 13:301-341.
3. Cox, D. R. (1972). Proportional models and life tables (with discussion). J. R. Stat. Soc. 34:87-220.
4. Cox, D. R. (1975). Partial likelihood. Biometrika 62:269-276.
5. Crowley, J., Hu, M. (1977). Covariance analysis of heart transplant survival data. J. Am. Stat. Assoc. 72:27-36.
6. Degruttola, V., Tu, X. M. (1994). Modeling progression of CD-4 lymphocyte count and its relationship to survival time. Biometrics 50:1003-1014.
7. Faucett, C. L., Schenker, N., Elashoff, R. M. (1998). Analysis of censored survival data with intermittently observed time-dependent binary covariates. J. Am. Stat. Assoc. 93:427-437.
8. Gail, M. H. (1981). Evaluating serial cancer marker studies in patients at risk of recurrent disease. Biometrics 37:67-78.
9. Halabi, S., Conaway, M. R., Small, E. J., Vogelzang, N. J., Dawson, N. A. (2001). Prostate specific antigen as an outcome variable: an analysis of cancer and leukemia group B (CALGB) study 9181. The Prostate J. 3:18-25.
10. Kantoff, P. W., Halabi, S., Conaway, M. R., Picus, J., Hars, V., Trump, D., Winer, E., Vogelzang, N. J. (1999). Hydrocortisone with or without mitoxantrone in men with hormone refractory prostate cancer: the results of CALGB 9182. J. Clin. Oncol. 17:2506-2513.
11. Li, K. H., Raghunathan, T. E., Rubin, D. B. (1991). Large-sample significance levels from multiply imputed data using moment-based statistics and an F reference distribution. J. Am. Stat. Assoc. 86:1065-1073.
12. Lipsitz, S. R., Ibrahim, J. G. (1996). Using the EM-Algorithm for survival data with incomplete categorical covariates. Lifetime Data Anal. 2:5-14.
13. Prentice, R. (1982). Covariate measurement errors and parameter estimates in a failure time regression time. Biometrika 69:331-342.
14. Rubin, D. B. (1987). Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons, Inc.
15. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. (1988). Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. J. Clin. Epidemiol. 41:1197-1208.
16. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. (1991). Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. J. Am. Med. Assoc. 265:3255-3264.
17. Tsiatis, A. A., Degruttola, V., Wulfsohn, M. S. (1995). Modeling the relationship of survival to longitudinal data with error: applications to survival and CD4 counts in patients with AIDS. J. Am. Stat. Assoc. 90:27-37.
18. Unnebrink, K., Jurgen, W. (2001). Intention-to-treat: methods for dealing with missing values in clinical trials of progressively deteriorating diseases. Stat. Med. 20:3931-3946.
19. Wulfsohn, M. S., Tsiatis, A. A. (1997). A joint model for survival and longitudinal data measured with error. Biometrics 53:330-339.